Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001625 · ClinicalTrials.gov registry record

Methods for Measuring Insulin Sensitivity

A clinical trial of Obesity and Hypertension, sponsored by National Center for Complementary and Integrative Health (NCCIH).

Completed
Registry status
480
Enrollment target
1
Study location

NCT00001625: Completed study of Obesity and Hypertension, sponsored by National Center for Complementary and Integrative Health (NCCIH).

NCT00001625 is a study of Obesity and Hypertension that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 480 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001625, a study of Obesity and Hypertension, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).

COMPLETED
Registry status
480 participants
Enrollment target
1
Study location

Study Summary

Patients with high blood pressure, diabetes, and who are overweight are known to have defects in the way their body responds to insulin. The purpose of this study is to develop better methods for measuring the way body tissue responds to insulin and sugar (glucose). Researchers are planning to study four groups of patients. 1. Normal volunteers 2. Patients who have mild to moderate high blood pressure 3. Patients who are overweight 4. Patients who have mild to moderate diabetes controlled with oral medication In this study patients and volunteers will undergo two separate tests designed to determine how well insulin is working in the body. The first test is called a glucose clamp test. Patients will have two needles placed in the veins of their arms. One needle will be used to take blood samples, the other needle will be used to inject doses of sugar (glucose) and insulin. The second test is called the frequently sample intravenous glucose tolerance test. In this test patients will have sugar (glucose) injected into their veins followed by a slow injected dose (infusion) of insulin. Researchers will periodically take blood samples during the test. Patients participating in the study will not directly benefit from it. However, the information gained from this study may be useful for improving the diagnosis and therapy of diseases such as diabetes, obesity, and high blood pressure (hypertension).

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda

Trial Details

FieldValue
Enrollment Target 480 participants
Start Date 1997-04-03
Est. Completion 2007-04-11

What the finished NCT00001625 record still lists

NCT00001625 is an observational study that tracks outcomes without assigning an intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (41% lower).

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.

NCT00001625 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00001625 about?

NCT00001625 is a clinical study titled "Methods for Measuring Insulin Sensitivity". Patients with high blood pressure, diabetes, and who are overweight are known to have defects in the way their body responds to insulin. The purpose of this study is to develop better methods for measuring the way body tissue responds to insulin and sugar (glucose). Researchers are planning to stud...

What is the current status of trial NCT00001625?

This trial is currently completed. The enrollment target is 480 participants. The study started on 1997-04-03. Estimated completion is 2007-04-11.

What conditions does trial NCT00001625 study?

This clinical trial studies the following conditions: Obesity, Hypertension, Diabetes Mellitus, Non-Insulin-Dependent.

Who is sponsoring clinical trial NCT00001625?

This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00001625 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00001625's enrollment target sits among peer trials

480 146th of 1053 higher than 908 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01954992 · 480 participants · Phase 3

    Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

  • NCT03023696 · 480 participants · NA

    Can Prophylactic Foraminotomy Prevent C5 Palsy

  • NCT04948060 · 480 participants · NA

    Tribally Engaged Approaches to Lung Screening (TEALS)

  • NCT05053230 · 480 participants · NA

    A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00001625, the US trial registry maintained by the National Library of Medicine. NCT00001625 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.